Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.2.0.727
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended 30 Months Ended
Mar. 17, 2015
Jun. 18, 2014
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Jun. 30, 2015
Due to stockholder             $ 92,717  
Related parties advance converted into common stock, shares         92,717      
Common stock, closing price per share $ 0.25              
Stock based compensation expense relating to directors officers and other related parties     $ 0 $ 56,559 $ 74,901 $ 437,187    
Eric Forman [Member]                
Legal and consulting fees charged to operations for services rendered by Eric Foreman     12,000 12,000 24,000 26,000    
Dr Kathleen P Mullinix [Member]                
Annual cash compensation     6,250 6,250 12,500 12,500 25,000  
Consulting Arrangements [Member]                
Clinical costs charged to operations               $ 1,202,536
Theradex Systems, Inc [Member]                
Clinical costs charged to operations     150,107 93,581 500,708 173,233    
Theradex Systems, Inc [Member] | Phase 1 Clinical [Member]                
Estimated total clinical cost to be charged to operations         $ 2,615,000      
Percentage of clinical trial service         60.00%      
Percentage of clinical center laboratory cost         40.00%      
Dr. Kovach [Member]                
Due to stockholder             $ 92,717  
Related parties advance converted into common stock, shares 92,717              
Common stock, effective price per share $ 1.00              
Common stock, closing price per share $ 0.25              
Salaries paid     $ 15,000 $ 15,000 $ 30,000 $ 30,000    
Eric Forman Law Office [Member]                
Sub-lease term   6 months            
Sub-lease base rate per month   $ 875